LCNB Corp’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $278K | Hold |
1,645
| – | – | 0.09% | 160 |
|
|
2025
Q4 | $278K | Hold |
1,645
| – | – | 0.09% | 159 |
|
|
2025
Q3 | $237K | Hold |
1,645
| – | – | 0.08% | 165 |
|
|
2025
Q2 | $208K | Hold |
1,645
| – | – | 0.07% | 179 |
|
|
2025
Q1 | $210K | Hold |
1,645
| – | – | 0.08% | 180 |
|
|
2024
Q4 | $217K | Hold |
1,645
| – | – | 0.08% | 172 |
|
|
2024
Q3 | $240K | Hold |
1,645
| – | – | 0.08% | 169 |
|
|
2024
Q2 | $226K | Sell |
1,645
-225
| -12% | -$30K | 0.08% | 168 |
|
|
2024
Q1 | $257K | Hold |
1,870
| – | – | 0.09% | 165 |
|
|
2023
Q4 | $254K | Sell |
1,870
-360
| -16% | -$43.9K | 0.1% | 162 |
|
|
2023
Q3 | $273K | Sell |
2,230
-200
| -8% | -$25.4K | 0.12% | 144 |
|
|
2023
Q2 | $309K | Sell |
2,430
-200
| -8% | -$26K | 0.13% | 139 |
|
|
2023
Q1 | $340K | Sell |
2,630
-390
| -13% | -$51.1K | 0.15% | 130 |
|
|
2022
Q4 | $396K | Hold |
3,020
| – | – | 0.18% | 123 |
|
|
2022
Q3 | $353K | Sell |
3,020
-200
| -6% | -$24.8K | 0.19% | 120 |
|
|
2022
Q2 | $379K | Hold |
3,220
| – | – | 0.2% | 119 |
|
|
2022
Q1 | $420K | Hold |
3,220
| – | – | 0.2% | 119 |
|
|
2021
Q4 | $491K | Sell |
3,220
-100
| -3% | -$15.5K | 0.22% | 107 |
|
|
2021
Q3 | $537K | Sell |
3,320
-250
| -7% | -$42.1K | 0.27% | 99 |
|
|
2021
Q2 | $584K | Hold |
3,570
| – | – | 0.29% | 94 |
|
|
2021
Q1 | $537K | Hold |
3,570
| – | – | 0.29% | 94 |
|
|
2020
Q4 | $541K | Hold |
3,570
| – | – | 0.31% | 88 |
|
|
2020
Q3 | $483K | Sell |
3,570
-205
| -5% | -$27.8K | 0.32% | 88 |
|
|
2020
Q2 | $516K | Sell |
3,775
-300
| -7% | -$38.2K | 0.35% | 79 |
|
|
2020
Q1 | $439K | Sell |
4,075
-99
| -2% | -$11.4K | 0.34% | 81 |
|
|
2019
Q4 | $503K | Sell |
4,174
-200
| -5% | -$22.3K | 0.31% | 80 |
|
|
2019
Q3 | $435K | Sell |
4,374
-447
| -9% | -$46.8K | 0.28% | 86 |
|
|
2019
Q2 | $526K | Hold |
4,821
| – | – | 0.37% | 72 |
|
|
2019
Q1 | $539K | Sell |
4,821
-660
| -12% | -$72.4K | 0.39% | 71 |
|
|
2018
Q4 | $529K | Sell |
5,481
-350
| -6% | -$37.1K | 0.44% | 66 |
|
|
2018
Q3 | $711K | Buy |
+5,831
| New | +$687K | 0.5% | 59 |
|
|
2018
Q2 | – | Sell |
-8,011
| Closed | -$855K | – | 123 |
|
|
2018
Q1 | $855K | Sell |
8,011
-890
| -10% | -$98.7K | 0.77% | 35 |
|
|
2017
Q4 | $950K | Sell |
8,901
-1,320
| -13% | -$141K | 0.84% | 31 |
|
|
2017
Q3 | $1.14M | Sell |
10,221
-75
| -0.7% | -$8.02K | 1.07% | 24 |
|
|
2017
Q2 | $1.06M | Sell |
10,296
-675
| -6% | -$66.5K | 1.04% | 25 |
|
|
2017
Q1 | $1.07M | Sell |
10,971
-195
| -2% | -$18.7K | 1.03% | 26 |
|
|
2016
Q4 | $988K | Buy |
+11,166
| New | +$1.02M | 0.98% | 28 |
|
Other funds holding IBB
CB
LCNB Corp's IBB Position: Q1 2026 in Review
LCNB Corp held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,645 shares worth $278K. The position accounts for 0.09% of the portfolio, ranked #160.
LCNB Corp first reported a position in IBB in Q4 2016 and has held it in 37 quarters since. The position peaked at $1.14M in Q3 2017. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- LCNB Corp held 1,645 shares of iShares Biotechnology ETF worth $278K as of Q1 2026.
- LCNB Corp left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.09% of LCNB Corp's portfolio in Q1 2026, its #160 holding.
- LCNB Corp first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 37 quarters since.
- LCNB Corp's iShares Biotechnology ETF position peaked at $1.14M in Q3 2017.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on LCNB Corp's 13F filing for Q1 2026, filed 11 May 2026.